Methamphetamine is a powerfully addictive psychostimulant that dramatically affects the mammalian central nervous system. Methylphenidate has been shown to have psychostimulus effects similar to methamphetamine. In the present study, we compared several effects of methylphenidate to those of methamphetamine. The subcutaneous administration of either methamphetamine or methylphenidate increased extracellular dopamine levels in the nucleus accumbens of mice. Interestingly, methamphetamine, but not methylphenidate, also increased the extracellular serotonin levels in this area. Further, repeated treatment with methamphetamine induced the development of sensitization to hyperlocomotion, whereas methylphenidate failed to induce behavioral sensitization. Moreover, in vitro treatment with methamphetamine, but not methylphenidate, caused long-lasting astrocytic activation in limbic neuron/glia co-cultures. These findings suggest that, unlike methamphetamine, methylphenidate shows a lack of development of behavioral sensitization to its hyperlocomotion and induces reversible astrocytic activation.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejphar.2007.06.062DOI Listing

Publication Analysis

Top Keywords

methamphetamine methylphenidate
16
behavioral sensitization
12
astrocytic activation
12
lack development
8
development behavioral
8
methylphenidate
8
reversible astrocytic
8
methamphetamine
8
methylphenidate increased
8
increased extracellular
8

Similar Publications

Misuse and accidental overdoses attributed to stimulants are escalating rapidly. These stimulants include methamphetamine, cocaine, amphetamine, ecstasy-type drugs, and prescription stimulants such as methylphenidate. Unlike opioids and alcohol, there are no therapies approved by the US Food and Drug Administration (FDA) to treat stimulant-use disorder.

View Article and Find Full Text PDF

Psychostimulants and social behaviors.

Front Pharmacol

April 2024

Centro de Investigación Biomédica y Aplicada (CIBAP), Escuela de Medicina, Facultad de Ciencias Médicas, Universidad de Santiago de Chile (USACH), Santiago, Chile.

Mounting evidence from animal models and human studies indicates that psychostimulants can significantly affect social behaviors. This is not surprising considering that the neural circuits underlying the regulation and expression of social behaviors are highly overlapped with those targeted by psychostimulants, which in most cases have strong rewarding and, consequently, addictive properties. In the present work, we provide an overview regarding the effects of illicit and prescription psychostimulants, such as cocaine, amphetamine-type stimulants, methylphenidate or modafinil, upon social behaviors such as social play, maternal behavior, aggression, pair bonding and social cognition and how psychostimulants in both animals and humans alter them.

View Article and Find Full Text PDF

University students frequently resort to psychostimulants to enhance their physical and mental performance and manage academic pressures. However, these substances can lead to dependence and other undesired symptoms, and little empirical data are available for relevant stakeholders, raising significant concerns in health care. Therefore, this study aims to characterize neurostimulant use among university students in Rio Grande do Sul, Brazil.

View Article and Find Full Text PDF
Article Synopsis
  • Preclinical and clinical studies have found that psychostimulants can cause brain dysfunctions and neurotoxic effects, alongside their potential for abuse.
  • The review highlights recent research from 2018 to 2023 on substances like amphetamine, cocaine, and caffeine, exploring their harmful impacts on the brain in both experimental models and humans.
  • Understanding the mechanisms behind these effects is essential for addressing the serious health risks associated with the increasing recreational use of these drugs among various age groups.
View Article and Find Full Text PDF
Article Synopsis
  • Drug checking helps individuals verify the identity and purity of drugs before use, and the CanTEST Health and Drug Checking Service is the first established service in Australia for this purpose.
  • Recently, three samples submitted to the service were expected to be known substances but turned out to be unidentified; further laboratory analysis ultimately revealed them to be new psychoactive substances not previously documented.
  • This case highlights the importance of drug checking as a tool for monitoring the unregulated drug market and ensuring safer consumption practices among users.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!